Medication & Safety
Return and Refund Policy: What to Check Before You Buy
A clear return and refund policy tells you a lot about a seller before anything goes wrong. Here is what to check before...
Every GLP-1 medication starts at a dose too low to produce much weight loss and builds gradually over weeks or months. This is not inefficiency in the schedule. It is the entire point of the schedule.
Why titration exists
The starting dose is deliberately sub-therapeutic. Its function is not to begin treating your weight. Its function is to let your digestive system adapt to slowed gastric emptying before the dose reaches a level that would otherwise cause severe nausea and vomiting.
Think of it as building tolerance to the mechanism itself, step by step, rather than delivering the full effect immediately and asking your gut to cope with a large sudden change.
The schedules compared
Tirzepatide (Mounjaro/Zepbound), from SURMOUNT-1: starts at 2.5 mg, increasing by 2.5 mg roughly every four weeks, up to a maximum 15 mg. Reaching the top dose takes approximately twenty weeks.
Semaglutide (Ozempic/Wegovy): starts at 0.25 mg, a dose that produces essentially no clinical effect on its own, increasing over 16 to 20 weeks depending on the specific escalation protocol used.
Liraglutide (Saxenda), from SCALE: starts at 0.6 mg, increasing weekly up to 3.0 mg over five weeks. This is considerably faster than the weekly injectables, reflecting liraglutide's shorter half-life and daily dosing.
The pattern across all of them: more weeks at each step for the more potent, longer-acting drugs, and correspondingly longer total time to reach full dose.
What happens if you skip steps
This is the single most common cause of severe, treatment-ending side effects.
Jumping to a higher dose without adequate adaptation time means your gut has not adjusted to the previous level of slowed emptying before facing an even greater slowing. The result is frequently severe nausea, vomiting, and in some cases dehydration significant enough to require medical attention.
People who rush titration are considerably more likely to stop treatment entirely, having concluded the drug is intolerable, when the actual issue was the pace rather than the medication itself at an appropriately built-up dose.
Staying longer versus pushing forward
This is a genuinely underused option. If a dose step is producing difficult side effects, staying at that dose for additional weeks before increasing further is almost always preferable to pushing on regardless.
There is no clinical requirement to advance on a fixed timeline if tolerance has not yet developed. The schedules published in trials represent a structure, not a mandate that must be followed regardless of how an individual is responding.
This is a conversation to have with whoever is supervising your treatment, but the principle is worth knowing in advance: slower is not failure.
Signs you may be escalating too fast
- Severe nausea that does not begin settling within several days of a dose increase
- Vomiting that prevents adequate fluid intake
- Inability to eat enough to avoid feeling unwell most of the day
- Side effects that are worsening rather than gradually improving at a given dose
Any of these is a signal to discuss holding at the current dose, or in some cases stepping back down, rather than continuing forward.
What titration does not do
Worth clarifying, since it connects to the assessment of whether treatment is working.
Titration does not mean early weeks reflect the drug's eventual effect. Assessing results at week six, while still on a sub-therapeutic dose, tells you very little about what the medication will do at full dose. This is a common source of premature disappointment.
It does not mean side effects should be absent at low doses. Some effect is normal even at starting doses, though it should generally be mild.
The behavioural adjustments that help during titration
- Eat smaller portions consistently, since your stomach is adapting to processing food more slowly regardless of dose
- Reduce fatty and fried food specifically during escalation, since fat slows gastric emptying further and compounds the effect
- Stay hydrated deliberately, since thirst is often blunted
- Avoid alcohol during active escalation, since it compounds nausea and dehydration risk
- Keep a symptom diary noting what happens after each increase, useful for the conversation about pace
Why supervision during titration matters specifically
This is the phase where most decisions about pace need to be made, and it is the phase most affected by whether anyone is actually monitoring the response.
Someone self-managing without guidance either pushes through severe side effects unnecessarily, concluding the drug does not suit them when a slower pace would have worked, or has no framework for deciding when to hold versus advance.
GLP-1 pathway support delivered as drops includes physician guidance on pacing as part of the process. METASLIM™ is a physician-reviewed sublingual supplement, and its own escalation follows the same underlying principle covered here: gradual adaptation rather than immediate full effect, with the review process available to discuss pace if needed.
Our guide to drug interactions with GLP-1 medication covers other factors worth discussing during this phase, and Mounjaro side effects covers what to expect at each dose specifically.
The summary
Starting doses are deliberately sub-therapeutic, existing to allow gut adaptation before reaching an effective level.
Titration schedules run from five weeks for liraglutide to roughly twenty weeks for tirzepatide and semaglutide, reflecting differences in potency and half-life.
Skipping or rushing steps is the most common cause of severe, treatment-ending side effects.
Staying longer at a tolerable dose before advancing is almost always preferable to pushing forward regardless of symptoms.
Assessing effectiveness during the escalation phase, before reaching full dose, produces a misleading picture.
Get started with a physician review that includes guidance on pacing your own escalation.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.